Ep.115 – Septic Shock and AKI: Do we still need to worry about piperacillin-tazobactam?
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Ep.115 – Septic Shock and AKI: Do we still need to worry about piperacillin-tazobactam?
-
Narrated by:
-
By:
About this listen
In this episode of the DASON Digest podcast, DASON clinical pharmacist liaison Dr. Angelina Davis talks with us about a national retrospective cohort study comparing the effects of cefepime versus piperacillin-tazobactam on the development of severe acute kidney injury in patients with septic shock. The article for this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/39657005/
For more information about DASON, please visit: https://dason.medicine.duke.edu/
No reviews yet